$8M Pharmacy NNN Acquisition Houston | Commercial Lending Solutions 
Loan Size Example

$8 Million Pharmacy NNN Acquisition in Houston

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy net lease acquisition in Houston represents a core-plus play for experienced CRE investors seeking stable, long-duration cash flow in a high-barrier-to-entry sector. These deals typically feature investment-grade or upper-mid-market tenants on 10 to 20-year leases with annual rent escalations, cap rates ranging from 5.5 to 6.75 percent depending on tenant credit and location strength. Lenders competing for Houston pharmacy NNN paper include national banks with dedicated single-tenant programs, life insurance companies focused on long-term holds, and CMBS conduit shops that value the lease durability and tenant covenant. At this loan size, borrowers achieve 65 to 75 percent LTV with rates hovering around 6.25 percent, reflecting current CMT-based pricing and modest execution risk.

Get a Quote on Your $8M Deal →
Capital Stack

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

The typical capital stack for an $8 million Houston pharmacy acquisition leans heavily on national bank single-tenant programs and regional life companies, which together control roughly 70 to 80 percent of the STNL market. Lender selection hinges on tenant credit quality, lease length, property location, and the borrower's appetite for recourse or non-recourse structures, with life companies preferred when non-recourse execution is required.

Capital Source Rate / Cost Size / LTV Notes
National bank with STNL program 6.15 to 6.35 percent, CMT-based with 225 to 275 basis point spread $5.2 to $6.0 million, 65 to 75 percent LTV Full recourse, 10-year amortization, 25-year term typical. Fast underwriting (45 to 60 days). Preferred structure for creditworthy borrowers with 1031 exchange intent.
Life insurance company 6.10 to 6.40 percent, fixed or CMT-based depending on product $3.0 to $4.5 million, 60 to 72 percent LTV Partial or full non-recourse available at lower LTV tiers. Longer hold preference (20+ years). Slower closing (75 to 90 days) but more flexibility on lease metrics and tenant diversification.
CMBS conduit lender 6.20 to 6.45 percent including servicing spread $4.8 to $6.4 million, 70 to 75 percent LTV Loan-to-cost orientation. Full recourse. Demands strong tenant credit (A- or better). Fastest execution for seasoned 1031 exchanges. Rates improve with longer lease terms (15+ years remaining).
Regional credit union or community bank 6.30 to 6.60 percent $2.0 to $3.5 million, 60 to 70 percent LTV Niche product for local borrowers or existing relationships. Slower underwriting. Less leverage available than national platforms. Useful as secondary financing or when primary lender declines.

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Sponsor Profile

Who Closes a $8M Pharmacy NNN Acquisition Deal

The typical $8 million Houston pharmacy NNN buyer is a seasoned net-lease investor or 1031 exchange buyer with $2 to $4 million in liquid equity and a track record of 5 to 15 prior single-tenant acquisitions. These sponsors value predictable cash flow, long-duration leases, and tenant stability over value-add upside and are often motivated by portfolio diversification, taxable gains redeployment via 1031 exchange, or retirement income structuring. Credit profiles and balance sheets are strong, with debt service coverage ratios typically 1.2 to 1.4 times and net worth well above $3 million.

From the CLS CRE Pipeline

A Real $8M Example

A regional buyer acquired a brand-new pharmacy NNN property in a Houston suburban submarket at an 5.8 percent cap rate. The loan amount was $6.2 million, representing 77.5 percent LTC on a $8.0 million all-in acquisition cost. A national bank offered 6.24 percent fixed for 25 years with a 10-year amortization, full recourse, and a 60-day closing. The tenant was a top-10 national pharmacy operator with an A-range credit rating and a 20-year initial lease term with annual 2 percent escalations. The borrower was a repeat 1031 exchange investor with $1.8 million equity down and prior pharmacy NNN experience. The deal closed on time, the borrower satisfied their exchange deadline, and the property has performed ahead of proforma rent collections to date.

Anonymized. All deal references protect borrower and lender identity.

FAQ

$8M Pharmacy NNN Acquisition Houston FAQ

Most lenders will offer $5.2 to $6.4 million in debt at 65 to 80 percent LTV, depending on tenant credit, lease length, and location strength. National banks dominate the 70 to 75 percent LTV range, while life companies can go lower (60 to 65 percent LTV) with non-recourse terms if needed. The spread between bank and life company pricing is typically 5 to 15 basis points in the borrower's favor for life company non-recourse options.
Top-10 national pharmacy operators (investment-grade or A-range) typically qualify for rates at the lower end of the 6.10 to 6.35 percent range with all lender types and maximum leverage (75 percent LTV). Mid-market or regional pharmacy tenants may see rates 15 to 25 basis points higher and lower leverage caps (70 to 72 percent LTV), with life companies more willing to lend below 65 percent LTV. Lenders also scrutinize lease remaining term; deals with fewer than 10 years remaining face rate penalties or leverage caps regardless of tenant quality.
Full non-recourse is available only from life insurance companies at LTVs typically below 65 to 67 percent, with rates 5 to 15 basis points above recourse bank offerings. Most deals at $8 million balance leverage and non-recourse desire by accepting full recourse from banks (lower rates, higher LTV) or partial recourse from life companies (middle ground). Borrowers seeking non-recourse must be prepared to accept lower leverage and longer closings (80 to 100 days).
National banks typically close in 50 to 70 days from formal application to funding, with strong pricing and streamlined underwriting. CMBS lenders close in 60 to 90 days and require more detailed loan structure and tenant analysis upfront. Life companies usually take 85 to 120 days, particularly if non-recourse terms or credit committee review is involved. All timelines assume a creditworthy borrower, investment-grade tenant, and clean property appraisal with no material defects.
Most bank single-tenant programs offer CMT-based floating or 5/10-year fixed options; at current market conditions, a 25-year term fixed at 6.24 to 6.30 percent is typical. Some life companies offer longer fixed terms (up to 30 years) at slight rate premiums (6.30 to 6.45 percent). Rate locks are typically good for 30 to 60 days from rate confirmation; CMT ceilings or floors are negotiable depending on lender appetite and term length.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.